Примери за използване на Clinical exposure на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
No such effect was seen at systemic exposure 49-times the maximal clinical exposure to linagliptin.
early embryonic development at exposures greater than 900-times the clinical exposure.
a reduced body weight was observed at systemic exposure levels similar to the expected clinical exposure.
rats there was no margin in clinical exposure.
dose-related CNS clinical signs started to be observed at systemic exposure levels below the expected clinical exposure.
The exposure of animals at the no observed effect level for aneugenicity was approximately 7 times human clinical exposure based on AUC.
Gastrointestinal effects were observed in the dog at systemic exposure levels equivalent to or less than the clinical exposure at the recommended doses.
Adverse reactions seen in animals at exposure levels similar to clinical exposure levels and with possible relevance to clinical use were as follows.
Adolescent primates dosed with denosumab at 27 and 150 times(10 and 50 mg/kg dose) the clinical exposure had abnormal growth plates.
11 times(females) the clinical exposure at the Maximum Recommended Human Dose(MRHD)
When given subcutaneously there were no effects at exposures 62-fold the human clinical exposure at a daily dose of 22 micrograms,
reduced weight gain of offspring was observed at maternal exposures approximately 4-times the maximal clinical exposure to empagliflozin.
rabbits at doses resulting in several hundredfold greater systemic exposures than the clinical exposure.
A no-effect level for these findings was found at an exposure 6-fold the clinical exposure level.
mild reversible liver changes were observed in rats starting at about 3 times the clinical exposure.
Further, hypospermatogenesis was observed in male dogs at exposure levels below human clinical exposure levels at intended therapeutic dose.
fold the clinical exposure(based on AUC).
effects did not occur(NOAEL) were in the same range as the clinical exposure or lower.
These effects occurred at systemic exposure levels that are equivalent to or less than the clinical exposure at the recommended dose of 2 g/ day for renal transplant recipients.
however a clinical exposure/response analysis revealed no evidence of clinically relevant effects of such an increase.